Clinical trials
Phase 1/2 Carcinoma, Hepatocellular trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 6 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| AstraZeneca | 2 |
| Rznomics, Inc. | 2 |
| Amgen | 1 |
| Arbutus Biopharma Corporation | 1 |
| BeOne Medicines | 1 |
| Cellestia Biotech AG | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Eisai Co., Ltd. | 1 |
| Eisai Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 28 |
| Liver Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Cholangiocarcinoma | 2 |
| Neoplasms | 2 |
| Bile Duct Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.